<DOC>
	<DOCNO>NCT01977625</DOCNO>
	<brief_summary>This study seek assess effect lisdexamfetamine ( trademark name : Vyvanse ; LDX ) executive function prefrontal cortex activation menopausal woman age 45-57 , report subjective cognitive difficulty . This protocol recruit woman Dr. Epperson 's ongoing study , Protocol # 812470 , examine impact LDX brain activation performance cognitive task specifically probe prefrontal cortex function .</brief_summary>
	<brief_title>LDX Functional Magnetic Resonance Imaging ( fMRI Menopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Lisdexamfetamine Dimesylate</mesh_term>
	<criteria>1 . Have previous present history DSMIV psychiatric substance dependence disorder within previous year , accord Structured Clinical Interview Diagnosis DSMIV ( SCID ) NonPatient Version ; 2 . Are within 5 year last menstrual period ( LMP ) ; 3 . Have follicular stimulate hormone level ( FSH ) 20 IU/ml ; 4 . Are able give write informed consent ; 5 . Must clear urine toxicology screen upon recruitment ; 6 . Are fluent write spoken English ; 7 . Are righthanded ; 8 . Negative urine pregnancy test still menstruate . 1 . Minimental status exam score less equal 24 ; 2 . Presence psychiatric disorder within previous year life time history ADHD psychotic disorder include bipolar disorder , schizoaffective disorder , schizophrenia ; 3 . Lifetime history drug addiction abuse , except nicotine ; 4 . Regular use psychotropic medication ; 5 . Regular use ( week ) alcohol le 3 drinks/day ; 6 . Presence contraindication treatment stimulant medication unless condition control medication ; would include presence uncontrolled hypertension , coronary disease , atrial fibrillation , arrhythmia ; 7 . History seizure ; 8 . History cardiac disease include know cardiac defect conduction abnormality ; 9 . Abnormal electrocardiogram screening ; 10 . Use estrogen therapy within previous 2 month ; 11 . Current pregnancy planning become pregnant ; 12 . Metallic implant ; 13 . Claustrophobia .</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Menopause</keyword>
	<keyword>fMRI</keyword>
	<keyword>Vyvanse</keyword>
</DOC>